Overview

Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the amount of ertapenem in the blood over time between hemodialysis session.
Phase:
Phase 2
Details
Lead Sponsor:
Oakwood Hospital and Medical Center
William Beaumont Hospitals
Collaborator:
Wayne State University
Treatments:
Ertapenem